BioCentury
ARTICLE | Company News

Immunotope, ImmunoVaccine Technologies deal

July 20, 2009 7:00 AM UTC

ImmunoVaccine received exclusive, worldwide rights to seven of Immunotope's cancer antigens. ImmunoVaccine will combine the antigens with its DepoVax vaccine delivery system. The vaccine will be calle...